RxDoctor Payments DataLook up a doctor →

Daniel Kloster, MD

Interventional Pain Medicine · Overland Park, KSNPI 1346237088

Payments from drug & device makers

$1,402,993in general payments, 2019–2025

Across 1,095 payments — averaging $1281.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$437K
  • Spinal Simplicity, LLC$377K
  • Flowonix Medical Incorporated$156K
  • Omnia Medical, LLC$82K
  • Vertiflex, Inc.$73K
  • Nevro Corp.$70K
  • plus $208K from 24 others
$115,740in research payments, 2019–2025

Across 4 payments — averaging $28,935 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Flowonix Medical Incorporated$115K
  • Nevro Corp.$590

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few interventional pain medicine providers in Kansasto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$336,775
Medicare patients
490
Services billed
3,592

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional pain medicine in Overland Park

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →